Metipranolol: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
mNo edit summary
Gerald Chi (talk | contribs)
mNo edit summary
Line 87: Line 87:
==Mechanism of Action==
==Mechanism of Action==


Metipranolol blocks beta1 and beta2 (non-selective) adrenergic receptors. It does not have significant intrinsic sympathomimetic activity, and has only weak local anesthetic (membrane-stabilizing) and myocardial depressant activity.
Metipranolol blocks beta1 and beta2 (non-selective) adrenergic receptors. It does not have significant intrinsic sympathomimetic activity, and has only weak local anesthetic (membrane-stabilizing) and myocardial depressant activity.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3#nlm34090-1 | publisher =  | date =  | accessdate = }}</ref>
 


==References==
==References==

Revision as of 05:17, 10 February 2014

Metipranolol
METIPRANOLOL® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Metipranolol
ClinicalTrials.gov
Metipranolol
File:Metipranolol.svg
Clinical data
Trade namesOptipranolol
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa601078
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H27NO4
Molar mass309.401 g/mol
3D model (JSmol)
  (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms / Brand Names: METIPRANOLOL

Overview

Metipranolol hydrochloride (OptiPranolol) is a non-selective beta blocker used in eye drops to treat glaucoma.

Category

Beta Blockers

FDA Package Insert

METIPRANOLOL solution/ drops

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Metipranolol blocks beta1 and beta2 (non-selective) adrenergic receptors. It does not have significant intrinsic sympathomimetic activity, and has only weak local anesthetic (membrane-stabilizing) and myocardial depressant activity.[1]


References

  1. "METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.]".

Template:Antiglaucoma preparations and miotics